CVS Health Corporation (NYSE:CVS) Shares Acquired by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund boosted its holdings in CVS Health Corporation (NYSE:CVS) by 0.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 108,312 shares of the pharmacy operator’s stock after acquiring an additional 460 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CVS Health were worth $7,338,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in CVS. Norges Bank acquired a new stake in CVS Health in the 4th quarter valued at about $839,574,000. Capital World Investors boosted its stake in shares of CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator’s stock worth $2,739,927,000 after purchasing an additional 12,819,148 shares during the last quarter. Davis Selected Advisers boosted its stake in shares of CVS Health by 2,998.1% during the 4th quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator’s stock worth $511,115,000 after purchasing an additional 11,018,438 shares during the last quarter. Dodge & Cox boosted its stake in shares of CVS Health by 11.2% during the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator’s stock worth $3,147,054,000 after purchasing an additional 7,075,209 shares during the last quarter. Finally, Pzena Investment Management LLC boosted its stake in shares of CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator’s stock worth $880,319,000 after purchasing an additional 6,475,271 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently weighed in on CVS shares. Robert W. Baird increased their price objective on shares of CVS Health from $51.00 to $71.00 and gave the stock a “neutral” rating in a report on Tuesday, April 15th. Piper Sandler increased their price objective on shares of CVS Health from $72.00 to $74.00 and gave the stock an “overweight” rating in a report on Friday, March 21st. UBS Group increased their price objective on shares of CVS Health from $67.00 to $71.00 and gave the stock a “neutral” rating in a report on Friday, May 2nd. Royal Bank Of Canada increased their price objective on shares of CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a report on Monday, May 5th. Finally, Truist Financial raised their price target on shares of CVS Health from $82.00 to $84.00 and gave the company a “buy” rating in a report on Monday, May 12th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $75.06.

CVS Health Stock Down 4.3%

CVS stock opened at $66.62 on Thursday. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $84.28 billion, a P/E ratio of 15.90, a PEG ratio of 1.00 and a beta of 0.57. The firm has a 50 day simple moving average of $65.03 and a 200-day simple moving average of $61.17.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the company earned $1.31 earnings per share. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. On average, equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the firm’s stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director directly owned 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.